OssaTron® Orthotripsy® is a non-invasive procedure for orthopedic applications. Orthotripsy utilizes the same technology as lithotripsy for kidney stones; very strong acoustic (sound) waves that produce a shock wave. Science has proven that shockwaves stimulate bone growth and promote the healing of tendinopathies.
When aimed at soft tissue that has developed scar tissue or is chronically inflamed, the shock wave will cause revascularization (increase circulation) to the area. The revascularization process initiates the body's natural healing process and in time decreases the inflammation to the tendon or fascia, thereby decreasing and eventually eliminating pain to the area.
There are two indications approved for OssaTron® Orthotripsy® by the Food and Drug Administration (FDA): chronic proximal plantar fasciitis, or heel pain syndrome, and chronic lateral epicondylitis, or tennis elbow. The OssaTron® is the first and only high energy, one time treatment, Extracorporeal Shock Wave device approved by the FDA to treat these painful conditions.
Other Diagnosis
OssaTron® Orthotripsy® is the only high energy, one time treatment device approved by the FDA, and the only machine that is FDA approved for multiple indications. Currently there are two diagnosis OssaTron® Orthotripsy® is approved for by the FDA; plantar fasciitis (heel pain syndrome) and lateral epicondylitis (tennis elbow).
OssaTron® Orthotripsy® has proven to be extremely beneficial to multiple tendinopathies and the only treatment of its kind to show success with non-union or delayed bone healing.
Contact Information
For insurance information, or general information about OssaTron® Orthotripsy® please call:
Innovations in Orthopaedics
405.619.4440
To contact a trained and participating physician in Oklahoma:
R.J. Langerman Jr., D.O.
8100 S. Walker
Oklahoma City, Oklahoma 73139
405-632-4468
877-632-4468
www.southwestortho.com